Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Flygare

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Future Oncology (London, England)|March 17, 2009
Development of novel drugs targeting inhibitors of apoptosisJohn A Flygare, Domagoj Vucic
Expert Opinion on Therapeutic Patents|January 27, 2010
Small-molecule pan-IAP antagonists: a patent reviewJohn A Flygare, Wayne J Fairbrother
Current Topics in Medicinal Chemistry|November 29, 2013
Inhibiting caspase-6 activation and catalytic activity for neurodegenerative diseasesJohn A Flygare, Michelle R Arkin
The Journal of Organic Chemistry|October 25, 2001
Solid-Phase Synthesis of 2-AminothiazolesPatrick C. Kearney, Monica Fernandez, John A. Flygare
Chemical Biology & Drug Design|December 21, 2012
Antibody-drug conjugates for the treatment of cancerJohn A Flygare, Thomas H Pillow, Paul Aristoff
The FEBS Journal|February 15, 2017
Activity-based probes for the ubiquitin conjugation-deconjugation machinery: new chemistries, new tools, and new insightsDavid S Hewings, John A Flygare, Matthew Bogyo, et al.
The FEBS Journal|January 21, 2017
Activity-based probes for the multicatalytic proteasomeDavid S Hewings, John A Flygare, Ingrid E Wertz, et al.
Bioconjugate Chemistry|February 14, 2023
Modification of Cysteine-Substituted Antibodies Using Enzymatic Oxidative Coupling ReactionsWendy Cao, Johnathan C Maza, Natalia Chernyak, et al.
ACS Chemical Biology|December 16, 2006
Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPsKerry Zobel, Lan Wang, Eugene Varfolomeev, et al.
Cell Chemical Biology|October 11, 2023
In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferinRyan L Gonciarz, Honglin Jiang, Linh Tram, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Future Oncology (London, England)|March 17, 2009
Development of novel drugs targeting inhibitors of apoptosisJohn A Flygare, Domagoj Vucic
Expert Opinion on Therapeutic Patents|January 27, 2010
Small-molecule pan-IAP antagonists: a patent reviewJohn A Flygare, Wayne J Fairbrother
Current Topics in Medicinal Chemistry|November 29, 2013
Inhibiting caspase-6 activation and catalytic activity for neurodegenerative diseasesJohn A Flygare, Michelle R Arkin
The Journal of Organic Chemistry|October 25, 2001
Solid-Phase Synthesis of 2-AminothiazolesPatrick C. Kearney, Monica Fernandez, John A. Flygare
Chemical Biology & Drug Design|December 21, 2012
Antibody-drug conjugates for the treatment of cancerJohn A Flygare, Thomas H Pillow, Paul Aristoff
The FEBS Journal|February 15, 2017
Activity-based probes for the ubiquitin conjugation-deconjugation machinery: new chemistries, new tools, and new insightsDavid S Hewings, John A Flygare, Matthew Bogyo, et al.
The FEBS Journal|January 21, 2017
Activity-based probes for the multicatalytic proteasomeDavid S Hewings, John A Flygare, Ingrid E Wertz, et al.
Bioconjugate Chemistry|February 14, 2023
Modification of Cysteine-Substituted Antibodies Using Enzymatic Oxidative Coupling ReactionsWendy Cao, Johnathan C Maza, Natalia Chernyak, et al.
ACS Chemical Biology|December 16, 2006
Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPsKerry Zobel, Lan Wang, Eugene Varfolomeev, et al.
Cell Chemical Biology|October 11, 2023
In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferinRyan L Gonciarz, Honglin Jiang, Linh Tram, et al.
Pageof 4